IDEAYA Biosciences (IDYA) Non-Current Assets (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Non-Current Assets data on file, last reported at $334.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 14.9% year-over-year to $334.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 8.58% YoY), and the FY2025 full-year result was $442.6 million, up 1.89% from the prior year.
• Non-Current Assets declined to $334.2 million in Q1 2026, from $442.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $442.6 million in Q4 2025 to a low of $17.5 million in Q3 2022.
• A 5-year average of $210.6 million and a median of $252.2 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets slumped 86.61% in 2022 and jumped 1113.07% in 2024, its largest moves.
• Tracing IDYA's Non-Current Assets over 5 years: stood at $17.5 million in 2022, then soared by 566.19% to $116.7 million in 2023, then surged by 272.27% to $434.4 million in 2024, then rose by 1.89% to $442.6 million in 2025, then decreased by 24.48% to $334.2 million in 2026.
• Business Quant data shows IDYA's Non-Current Assets at $334.2 million in Q1 2026, $442.6 million in Q4 2025, and $382.5 million in Q3 2025.